Rocket Pharmaceuticals, Inc. (RCKT)

Rocket Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	32.82	163.64	55.9	140.52	232.69	297.1
Short-Term Investments	238.68	208.7	317.27	215.88	156.05	185.62
Cash & Short-Term Investments	271.49	372.34	373.18	356.39	388.74	482.72
Cash Growth	-2.63%	-0.22%	4.71%	-8.32%	-19.47%	58.73%
Prepaid Expenses	5.66	5.85	5.05	7.67	3.32	4.63
Total Current Assets	277.16	378.18	378.22	364.06	392.06	487.35
Property, Plant & Equipment	77.64	83.32	87.59	77.65	72.35	70.64
Long-Term Investments	-	-	34.32	43.28	-	-
Goodwill	39.15	39.15	39.15	39.15	30.82	30.82
Other Intangible Assets	25.15	25.15	25.15	25.72	-	-
Other Long-Term Assets	1.88	1.89	1.91	1.95	1.8	2.02
Total Assets	420.98	527.7	566.34	551.81	497.02	590.82
Accounts Payable	1.71	1.63	1.77	2.27	0.48	0.84
Accrued Expenses	35.33	36.02	29.8	30.54	17.81	22.29
Current Portion of Long-Term Debt	-	-	-	-	-	4.88
Current Portion of Leases	2.89	2.86	2.72	2.51	2.55	2.27
Current Unearned Revenue	-	-	-	0.6	0.6	0.59
Other Current Liabilities	3.47	0.19	14.21	3.25	0.73	1.76
Total Current Liabilities	43.4	40.68	48.51	39.17	22.17	32.62
Long-Term Debt	-	-	-	-	-	35.07
Long-Term Leases	22.31	22.64	22.33	20.36	20.05	19.49
Other Long-Term Liabilities	1.06	1.14	2.94	2.6	0.08	0.14
Total Liabilities	66.77	64.47	73.77	62.12	42.3	87.31
Common Stock	1.08	1.07	0.9	0.79	0.65	0.61
Additional Paid-In Capital	1,702	1,680	1,451	1,203	946.15	825.79
Retained Earnings	-1,348	-1,218	-959.37	-713.78	-491.91	-322.84
Treasury Stock	-	-	-	-0.05	-	-
Comprehensive Income & Other	-0.11	0.07	0.32	-0.36	-0.16	-0.04
Total Common Equity	354.21	463.23	492.57	489.69	454.72	503.52
Shareholders' Equity	354.21	463.23	492.57	489.69	454.72	503.52
Total Liabilities & Equity	420.98	527.7	566.34	551.81	497.02	590.82
Total Debt	25.2	25.5	25.04	22.87	22.6	61.7
Net Cash (Debt)	246.29	346.84	348.13	333.53	366.14	421.02
Net Cash Growth	-2.66%	-0.37%	4.38%	-8.91%	-13.04%	64.03%
Net Cash Per Share	2.39	3.66	4.14	4.89	5.79	7.60
Filing Date Shares Outstanding	107.9	106.63	90.5	79.35	64.51	61.78
Total Common Shares Outstanding	107.88	106.45	90.28	79.12	64.51	61
Working Capital	233.76	337.5	329.72	324.89	369.89	454.73
Book Value Per Share	3.28	4.35	5.46	6.19	7.05	8.25
Tangible Book Value	289.91	398.93	428.27	424.81	423.91	472.7
Tangible Book Value Per Share	2.69	3.75	4.74	5.37	6.57	7.75
Machinery	49.04	48.85	44.58	35.61	25.21	19.84
Leasehold Improvements	7.33	7.28	6.72	0.59	0.41	0.03

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q